Bevacizumab Biosimilar

About Hansoh Pharma

Hansoh Pharmaceutical Group is one of China's premier pharmaceutical companies, specializing in innovative drug development across oncology, central nervous system disorders, and other therapeutic areas. Founded in 1995, the company has successfully commercialized multiple products in China and is expanding its pipeline with novel small molecules and biologics. Hansoh went public on the Hong Kong Stock Exchange in 2019 and continues to invest heavily in R&D to develop first-in-class and best-in-class therapies.

About Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Limited is a research-driven global pharmaceutical company founded in 1977 and headquartered in Mumbai, India. The company operates across the pharmaceutical value chain with significant investments in R&D, particularly in respiratory diseases, dermatology, and oncology. Glenmark has successfully developed and commercialized innovative drugs while building a strong generic pharmaceuticals portfolio across key markets including the US, Europe, and emerging markets.

About Changchun High-Tech Industry

Changchun High-Tech is a prominent, revenue-generating biopharmaceutical enterprise in China, primarily known for its vaccine business. Its strategic position is anchored by its controlling stake in Changchun BCHT Biotechnology, a critical supplier of the Varicella vaccine in the domestic market. The company leverages this established commercial foundation to invest in and develop a broader pipeline of biological products, including monoclonal antibodies and other innovative therapeutics. As a publicly listed entity, it operates with a diversified business model that also includes investments in real estate and other industries.

About Alembic Pharmaceuticals

Alembic Pharmaceuticals is a vertically integrated, publicly listed Indian pharmaceutical company with a century-long legacy. It operates through two main segments: Generics and Branded Generics, with a robust manufacturing infrastructure and a growing international footprint, particularly in the US market. The company is strategically focused on complex generics, biosimilars, and specialty products to drive future growth, supported by significant R&D investments.

About Strides Pharma

Strides Pharma is a global pharmaceutical company headquartered in Bengaluru, India, with a core mission to provide affordable, high-quality generic medicines worldwide. The company has established itself as a leader in niche and complex therapeutic segments, including anti-retrovirals, anti-malarials, and softgel technologies, with a significant footprint in the US, Africa, Asia, and other regulated markets. Its strategic direction involves expanding its portfolio of complex generics, biosimilars, and specialty products while leveraging its robust manufacturing and R&D capabilities. Key achievements include a successful IPO, strategic acquisitions, and a consistent track record of ANDA filings and approvals in the US market.

Therapeutic Areas